Cargando…

Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey

BACKGROUND: The aim of this study was to identify practice differences in the treatment of carbon monoxide (CO) poisoning with or without hyperbaric oxygen (HBO(2)) therapy in Japan. MATERIALS AND METHODS: Using an online survey website (Google form), we created a questionnaire and invited intereste...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Motoki, Oda, Yasutaka, Kaneda, Kotaro, Kawamura, Yoshikatsu, Nakahara, Takashi, Todani, Masaki, Yagi, Takeshi, Koga, Yasutaka, Tsuruta, Ryosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304618/
https://www.ncbi.nlm.nih.gov/pubmed/30627443
http://dx.doi.org/10.1155/2018/2159147
_version_ 1783382402103508992
author Fujita, Motoki
Oda, Yasutaka
Kaneda, Kotaro
Kawamura, Yoshikatsu
Nakahara, Takashi
Todani, Masaki
Yagi, Takeshi
Koga, Yasutaka
Tsuruta, Ryosuke
author_facet Fujita, Motoki
Oda, Yasutaka
Kaneda, Kotaro
Kawamura, Yoshikatsu
Nakahara, Takashi
Todani, Masaki
Yagi, Takeshi
Koga, Yasutaka
Tsuruta, Ryosuke
author_sort Fujita, Motoki
collection PubMed
description BACKGROUND: The aim of this study was to identify practice differences in the treatment of carbon monoxide (CO) poisoning with or without hyperbaric oxygen (HBO(2)) therapy in Japan. MATERIALS AND METHODS: Using an online survey website (Google form), we created a questionnaire and invited interested institutions to join the COP-J Study, a prospective observational study of CO poisoning in Japan. RESULTS: Forty-eight (63%) of 76 institutions replied to the questionnaire. Thirty-three institutions (69%) administered HBO(2) therapy to patients with CO poisoning, and 15 institutions (31%) did not. Consciousness disturbance on arrival, exposure to CO for a long time, and elevation of arterial carboxyhemoglobin (CO-Hb) were the major indications for HBO(2) therapy. The maximum therapeutic pressures were 2.0, 2.5, and 2.8 atmospheres absolute (ATA) at 19 (58%), 6 (18%), and 8 (24%) institutions, respectively. The number of HBO(2) sessions on the first day was 1–3, and 1–7 sessions were administered on days 2–7. Seventeen (35%) institutions treated patients with delayed neurological sequelae (DNS) and 15 of them used HBO(2) therapy for DNS. CONCLUSIONS: This survey indicates that HBO(2) therapy for CO poisoning was varied in both the indications and practice regimens used in Japan.
format Online
Article
Text
id pubmed-6304618
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63046182019-01-09 Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey Fujita, Motoki Oda, Yasutaka Kaneda, Kotaro Kawamura, Yoshikatsu Nakahara, Takashi Todani, Masaki Yagi, Takeshi Koga, Yasutaka Tsuruta, Ryosuke Emerg Med Int Research Article BACKGROUND: The aim of this study was to identify practice differences in the treatment of carbon monoxide (CO) poisoning with or without hyperbaric oxygen (HBO(2)) therapy in Japan. MATERIALS AND METHODS: Using an online survey website (Google form), we created a questionnaire and invited interested institutions to join the COP-J Study, a prospective observational study of CO poisoning in Japan. RESULTS: Forty-eight (63%) of 76 institutions replied to the questionnaire. Thirty-three institutions (69%) administered HBO(2) therapy to patients with CO poisoning, and 15 institutions (31%) did not. Consciousness disturbance on arrival, exposure to CO for a long time, and elevation of arterial carboxyhemoglobin (CO-Hb) were the major indications for HBO(2) therapy. The maximum therapeutic pressures were 2.0, 2.5, and 2.8 atmospheres absolute (ATA) at 19 (58%), 6 (18%), and 8 (24%) institutions, respectively. The number of HBO(2) sessions on the first day was 1–3, and 1–7 sessions were administered on days 2–7. Seventeen (35%) institutions treated patients with delayed neurological sequelae (DNS) and 15 of them used HBO(2) therapy for DNS. CONCLUSIONS: This survey indicates that HBO(2) therapy for CO poisoning was varied in both the indications and practice regimens used in Japan. Hindawi 2018-12-04 /pmc/articles/PMC6304618/ /pubmed/30627443 http://dx.doi.org/10.1155/2018/2159147 Text en Copyright © 2018 Motoki Fujita et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Fujita, Motoki
Oda, Yasutaka
Kaneda, Kotaro
Kawamura, Yoshikatsu
Nakahara, Takashi
Todani, Masaki
Yagi, Takeshi
Koga, Yasutaka
Tsuruta, Ryosuke
Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey
title Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey
title_full Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey
title_fullStr Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey
title_full_unstemmed Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey
title_short Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey
title_sort variability in treatment for carbon monoxide poisoning in japan: a multicenter retrospective survey
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304618/
https://www.ncbi.nlm.nih.gov/pubmed/30627443
http://dx.doi.org/10.1155/2018/2159147
work_keys_str_mv AT fujitamotoki variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey
AT odayasutaka variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey
AT kanedakotaro variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey
AT kawamurayoshikatsu variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey
AT nakaharatakashi variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey
AT todanimasaki variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey
AT yagitakeshi variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey
AT kogayasutaka variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey
AT tsurutaryosuke variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey